Asthmatic crisis

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Upstream Bio Inc. Commercial
    HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST CRLF2
    2023-507410-27-00 6 countries 2024 n=182
    Ended
  • Upstream Bio Inc. Commercial
    HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST CRLF2
    2024-519469-23-00 6 countries 2025 n=123
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Upstream Bio Inc. Commercial 2 Phase II 0
New trials by year
2024
1
2025
1
← All indication landscapes